Form 4: Shattuck Labs CEO Granted 1.5M Stock Options

Shattuck Labs, Inc. CEO Taylor Schreiber was granted 1,548,300 stock options with an exercise price of $4.75, vesting over four years.

Summary

• Taylor Schreiber, Chief Executive Officer and Director of Shattuck Labs, Inc. (STTK), was granted 1,548,300 stock options.
• The stock options have an exercise price of $4.75 per share.
• The grant date for these options was January 10, 2026.
• The options will vest over a four-year period: one quarter (25%) will vest on January 10, 2027, and the remaining three quarters (75%) will vest in equal monthly installments through January 10, 2030.
• The expiration date for these stock options is January 10, 2036.
• The vesting is contingent upon Mr. Schreiber's continued service to the Issuer.

Sentiment

Score: 7

Explanation: The filing reports a significant stock option grant to the CEO, which is generally a positive signal for executive alignment and retention. While it doesn't reflect immediate financial performance, it indicates a long-term incentive structure. The potential for future dilution is a minor negative, but the overall sentiment leans positive due to the alignment of interests.

Positives

• The grant of a significant number of stock options to the CEO aligns management's long-term interests with those of shareholders, incentivizing future stock price appreciation.
• The 10-year expiration date provides a long-term horizon for the CEO to realize value, encouraging sustained strategic focus.

Negatives

• The future exercise of these options could lead to dilution for existing shareholders, increasing the total number of outstanding shares.
• The value of these options is entirely dependent on the company's stock price exceeding the $4.75 exercise price, meaning they could become worthless if the stock underperforms.

Risks

• Potential future dilution of existing shareholders if the options are exercised.
• The options' value is subject to market fluctuations; if the stock price remains below the exercise price, the options will not be 'in the money' and may not be exercised.

Future Outlook

The stock option grant incentivizes the CEO to drive long-term shareholder value, as the options' value is directly tied to the future appreciation of Shattuck Labs' common stock above the $4.75 exercise price. The vesting schedule encourages continued service and sustained performance over the next four years.

Industry Context

The grant of stock options to a Chief Executive Officer is a standard practice in the biotechnology and pharmaceutical industries, as well as across publicly traded companies, to attract, retain, and incentivize key executives. This compensation structure aims to align executive performance with shareholder returns, particularly in growth-oriented sectors like biotech where long-term value creation is paramount.

Comparison to Industry Standards

• The grant of stock options as a significant component of executive compensation is a common practice across the biotechnology and broader public company landscape.
• The four-year vesting schedule with a one-year cliff and subsequent monthly vesting is a typical structure designed to ensure executive retention and long-term commitment.
• The size of the grant (1.548 million options) for a CEO of a company like Shattuck Labs (STTK) is substantial and generally comparable to grants seen in similar-sized or growth-stage biotech firms, reflecting the importance of executive incentives in this sector.

Related Party Transactions

• The grant of stock options to Taylor Schreiber, the Chief Executive Officer and a Director, constitutes a related party transaction as it involves compensation provided by the company to a key executive.

Stakeholder Impact

• Shareholders: Potential for future dilution upon exercise of options, but also benefit from incentivized management performance.
• Employees: May view this as a positive signal regarding executive commitment and company future.
• Management (Taylor Schreiber): Receives significant long-term incentive compensation tied to company performance and continued service.

Next Steps

• Continued service of the Reporting Person to the Issuer for the options to vest.
• Monitoring of Shattuck Labs' stock performance relative to the $4.75 exercise price.

Key Dates

Keywords

Shattuck Labs, STTK, Stock Options, CEO Compensation, Executive Grant, Form 4, Insider Transaction, Taylor Schreiber, Equity Compensation, Vesting Schedule